QuickView for c-MYC;jsessionid=5D314ADDB3AC28D40A92492569460247;jsessionid=109E3114723493C0B3856284D03206C3 (gene)

1. Survey of activation-induced genome architecture reveals a novel enhancer of Myc.
2. Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target i…
3. MYC overexpression leads to increased chromatin interactions at super-enhancers and MYC binding site…
4. Therapeutic targeting of "undruggable" MYC.
5. Development and Characterization of Benzoselenazole Derivatives as Potent and Selective c-MYC Transc…

There were no clinical trials for c-MYC;jsessionid=5D314ADDB3AC28D40A92492569460247;jsessionid=109E3114723493C0B3856284D03206C3